AU748080B2 - Anti-inositolphosphoglycan monoclonal antibodies - Google Patents

Anti-inositolphosphoglycan monoclonal antibodies Download PDF

Info

Publication number
AU748080B2
AU748080B2 AU29467/99A AU2946799A AU748080B2 AU 748080 B2 AU748080 B2 AU 748080B2 AU 29467/99 A AU29467/99 A AU 29467/99A AU 2946799 A AU2946799 A AU 2946799A AU 748080 B2 AU748080 B2 AU 748080B2
Authority
AU
Australia
Prior art keywords
ipg
antibody
ipgs
antibodies
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU29467/99A
Other languages
English (en)
Other versions
AU2946799A (en
Inventor
Jose Mato
Isabel Varela Nieto
Jesus Prieto
Thomas William Rademacher
Phillip Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rodaris Pharmaceuticals Ltd
Original Assignee
Rodaris Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9805739.1A external-priority patent/GB9805739D0/en
Priority claimed from GBGB9811000.0A external-priority patent/GB9811000D0/en
Application filed by Rodaris Pharmaceuticals Ltd filed Critical Rodaris Pharmaceuticals Ltd
Publication of AU2946799A publication Critical patent/AU2946799A/en
Assigned to RODARIS PHARMACEUTICALS LIMITED reassignment RODARIS PHARMACEUTICALS LIMITED Amend patent request/document other than specification (104) Assignors: RADEMACHER GROUP LIMITED
Application granted granted Critical
Publication of AU748080B2 publication Critical patent/AU748080B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU29467/99A 1998-03-18 1999-03-18 Anti-inositolphosphoglycan monoclonal antibodies Ceased AU748080B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9805739 1998-03-18
GBGB9805739.1A GB9805739D0 (fr) 1998-03-18 1998-03-18
GBGB9811000.0A GB9811000D0 (fr) 1998-05-21 1998-05-21
GB9811000 1998-05-21
PCT/GB1999/000844 WO1999047565A1 (fr) 1998-03-18 1999-03-18 Anticorps monoclonaux anti-inositolphosphoglyanne

Publications (2)

Publication Number Publication Date
AU2946799A AU2946799A (en) 1999-10-11
AU748080B2 true AU748080B2 (en) 2002-05-30

Family

ID=26313300

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29467/99A Ceased AU748080B2 (en) 1998-03-18 1999-03-18 Anti-inositolphosphoglycan monoclonal antibodies

Country Status (5)

Country Link
EP (1) EP1062246A1 (fr)
JP (1) JP2002506631A (fr)
AU (1) AU748080B2 (fr)
CA (1) CA2321113A1 (fr)
WO (1) WO1999047565A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000039285A2 (fr) * 1998-12-24 2000-07-06 University College London Proteines d phospholipase specifiques du glycosyl phosphatidy linositol et leurs utilisations
WO2001086292A2 (fr) * 2000-05-12 2001-11-15 Rodaris Pharmaceutical Limited Dosages biologiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9505658D0 (en) * 1995-03-21 1995-05-10 Univ London Hormone and growth factor mimetics
GB9618931D0 (en) * 1996-09-11 1996-10-23 Univ London Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes
GB9618934D0 (en) * 1996-09-11 1996-10-23 Univ London Inositol phosphoglycans for therapeutic use in the treatment of diabetes and obesity
GB9618929D0 (en) * 1996-09-11 1996-10-23 Univ London Metal containing carbohydrates from human tissue which regulate glycogen metabolism
GB9618930D0 (en) * 1996-09-11 1996-10-23 Univ London Metal containing carbohydrates from human tissue which regulate lipogenic activity

Also Published As

Publication number Publication date
CA2321113A1 (fr) 1999-09-23
JP2002506631A (ja) 2002-03-05
WO1999047565A1 (fr) 1999-09-23
AU2946799A (en) 1999-10-11
EP1062246A1 (fr) 2000-12-27

Similar Documents

Publication Publication Date Title
DE69936780T2 (de) Antikörper gegen eine lar-phosphatase untereinheit
JP3758686B2 (ja) Ｃペプチド特異的アッセイ法
Lee et al. The murine lymphocyte receptor for IgE. IV. The mechanism of ligand-specific receptor upregulation on B cells.
DE60025008T2 (de) Bestimmung von adrenomedullin-bindenden proteinen
US9783600B2 (en) Apolipoprotein C3 (ApoCIII) antagonists and methods of their use to remove ApoCIII inhibition of lipoprotein lipase (LPL)
Merlie et al. Acetylcholine receptor degradation in adult rat diaphragms in organ culture and the effect of anti-acetylcholine receptor antibodies.
JP2007536212A (ja) レプチンアンタゴニストおよびレプチン定量測定方法
KR20080106157A (ko) Ｆａｓ 결합 항체
JPH09507578A (ja) インスリン受容体チロシンキナーゼインヒビターに対するアンタゴニスト
JPWO2008018472A1 (ja) 新規モノクローナル抗体およびその用途
Ma et al. Quantitative immunohistochemical analysis of islet amyloid polypeptide (IAPP) in normal, impaired glucose tolerant, and diabetic cats
US7732147B2 (en) Neurotransmission disorders
EP0443599B1 (fr) Méthode pour la détection des des antigènes associés aux tumeurs
JP2001519894A (ja) リソソーム蓄積症の早期検出法
JPH09507754A (ja) 哺乳類悪性細胞の選択的メチオニン飢餓方法
AU748080B2 (en) Anti-inositolphosphoglycan monoclonal antibodies
Yamamoto et al. Immunohistochemistry for anti-diabetes drug, alogliptin using a newly prepared monoclonal antibody: Its precise localization in rat small intestine
US20040192586A1 (en) Materials and methods relating to anti-inositolphosphoglycan antibodies
US6777394B1 (en) Methods and compositions for regulating imidazoline receptors
JP2792651B2 (ja) ヒト膵臓癌に対するモノクローナル抗体
Fujimiya et al. Immuno-electron microscopic study of differential localization of motilin and serotonin in the rabbit duodenal epithelium
DE60216482T2 (de) Zusammensetzungen und verfahren zum bestimmen von aa4rp
AU2946899A (en) Materials and methods relating to identifying inositolphosphoglycan mimetics
WO2005017484A2 (fr) Methodes d'identification de composes permettant de reguler la masse ou la fonction musculaire utilisant des recepteurs de la dopamine
CA2408648A1 (fr) Dosages biologiques

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: RODARIS PHARMACEUTICALS LIMITED

Free format text: FORMER NAME: RADEMACHER GROUP LIMITED

FGA Letters patent sealed or granted (standard patent)